Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PeptiDream | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 375.23B | 21.9x | 0.1 | JPY 2,884.50 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.1% Upside | Upgrade to Pro+ | |
GNI | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 152.44B | 22.1x | 0.06 | JPY 3,045 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Takara Bio | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 129.69B | -10.75 | JPY 1,074 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.5% Upside | Upgrade to Pro+ | ||
Sanbio Company | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 70B | -31.7x | -0.56 | JPY 1,020 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.9% Upside | Upgrade to Pro+ | |
Shin Nippon Biomed Lab | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 60.03B | 15.5x | -0.99 | JPY 1,441 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1% Downside | Upgrade to Pro+ | |
Pharma Foods | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 27.45B | 8.7x | 1.59 | JPY 978 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Healios K K | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 16.94B | -2.8x | 0.13 | JPY 188 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MediciNova | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 14B | -11.5x | -0.26 | JPY 296 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AnGes | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 12.51B | -0.03 | JPY 50 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
PRISM BioLab | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 11.51B | JPY 314 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
NanoCarrier | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 11.37B | -17.4x | JPY 162 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Tsubota Laboratory | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 11.08B | -17.5x | 0.02 | JPY 429 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3-D Matrix | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 10.63B | -8.2x | -0.18 | JPY 110 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medinet | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 10.05B | -1.7x | JPY 39 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
TMS | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 8.43B | -6.5x | 0.19 | JPY 211 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OncoTherapy | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 8.42B | -0.47 | JPY 30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Linical Co Ltd | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 7.7B | 30.5x | -0.45 | JPY 339 | -6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.5% Upside | Upgrade to Pro+ | |
NoileImmune Biotech | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 7.1B | -9.1x | JPY 161 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Modalis | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 6.35B | -2.5x | -0.07 | JPY 124 | 10.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chiome Bioscience | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 6.18B | -4.8x | -0.46 | JPY 101 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Veritas In Silico | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 5.73B | 60.6x | JPY 897 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kringle | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 5.55B | 0.42 | JPY 785 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Carna Biosciences | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 5.5B | -3.3x | -0.12 | JPY 287 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Chip Research | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 4.82B | -39.6x | -0.64 | JPY 712 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kidswell Bio | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 4.47B | -6.3x | JPY 110 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cyfuse Biomedical KK | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 4.26B | -7.7x | -0.25 | JPY 482 | -10.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Funpep | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 4.19B | -4.7x | JPY 131 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
BrightPath Biotherapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 4.06B | -1.1x | JPY 50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Human Metabolome Tech | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 3.49B | 14.3x | -0.98 | JPY 587 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ribomic | Tokyo | Healthcare | Biotechnology & Medical Research | JPY 3.21B | -3x | -0.09 | JPY 80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |